Impetigo and drug-induced skin disorders: management MCQs With Answer

Impetigo and drug-induced skin disorders: management MCQs With Answer

This quiz collection is designed for M.Pharm students studying Pharmacotherapeutics I (MPP 102T). It focuses on clinical management, pharmacology, and practical decision-making for impetigo and drug-induced cutaneous reactions (including SJS/TEN, DRESS, AGEP). Questions emphasize drug selection (topical vs systemic), mechanisms of action, resistance and MRSA considerations, dosing/duration principles, adjunctive measures, and evidence-based approaches to severe immune‑mediated skin reactions — including when to stop offending drugs and use systemic immunomodulators (steroids, IVIG, cyclosporine). Answers are provided to reinforce learning and prepare students for clinical reasoning and examination-level problem solving.

Q1. Which organism is the predominant cause of non-bullous impetigo in children?

  • Staphylococcus aureus (predominant cause)
  • Streptococcus pneumoniae
  • Pseudomonas aeruginosa
  • Candida albicans

Correct Answer: Staphylococcus aureus (predominant cause)

Q2. What is the recommended first-line topical antibiotic for localized impetigo in most guidelines?

  • Mupirocin ointment
  • Topical clotrimazole
  • Topical hydrocortisone cream
  • Oral amoxicillin

Correct Answer: Mupirocin ointment

Q3. For extensive impetigo requiring systemic therapy in a pediatric patient, which oral antibiotic is commonly preferred targeting methicillin-sensitive Staphylococcus aureus (MSSA)?

  • Oral flucloxacillin (anti-staphylococcal penicillin)
  • Oral amoxicillin–clavulanate
  • Oral azithromycin
  • Oral metronidazole

Correct Answer: Oral flucloxacillin (anti-staphylococcal penicillin)

Q4. If community-associated MRSA is a suspected cause of impetigo, which oral agent is an appropriate outpatient choice for older children or adults?

  • Trimethoprim–sulfamethoxazole (effective against community MRSA)
  • Penicillin V
  • Oral cephalexin (ineffective against many MRSA strains)
  • Topical amphotericin B

Correct Answer: Trimethoprim–sulfamethoxazole (effective against community MRSA)

Q5. What is the typical recommended duration of topical mupirocin treatment for localized impetigo?

  • 3 days
  • 5 days
  • 10 days
  • 14 days

Correct Answer: 5 days

Q6. What is the primary mechanism of antibacterial action of mupirocin?

  • Inhibition of bacterial isoleucyl‑tRNA synthetase
  • Inhibition of peptidoglycan cross-linking (transpeptidase)
  • DNA gyrase inhibition
  • 30S ribosomal subunit blockade

Correct Answer: Inhibition of bacterial isoleucyl‑tRNA synthetase

Q7. Which statement best describes the role of antiseptic washes (e.g., chlorhexidine) in impetigo management?

  • They are first-line monotherapy for extensive impetigo
  • They are useful adjuncts to reduce skin bacterial colonization and household transmission
  • They cure systemic complications of impetigo
  • They should be avoided because they increase resistance

Correct Answer: They are useful adjuncts to reduce skin bacterial colonization and household transmission

Q8. Which post-infectious complication is classically associated with streptococcal impetigo?

  • Post‑streptococcal glomerulonephritis
  • Rheumatoid arthritis
  • Stevens‑Johnson syndrome
  • Herpes zoster reactivation

Correct Answer: Post‑streptococcal glomerulonephritis

Q9. Which drug-induced reaction is characterized by widespread epidermal necrosis with full‑thickness epidermal detachment and mucosal involvement?

  • Stevens–Johnson syndrome / toxic epidermal necrolysis (SJS/TEN)
  • Drug reaction with eosinophilia and systemic symptoms (DRESS)
  • Acute generalized exanthematous pustulosis (AGEP)
  • Fixed drug eruption

Correct Answer: Stevens–Johnson syndrome / toxic epidermal necrolysis (SJS/TEN)

Q10. What is the immediate first step when a severe cutaneous adverse reaction (e.g., SJS/TEN, DRESS) is suspected?

  • Immediately discontinue the suspected offending drug(s)
  • Start high‑dose oral antibiotics
  • Apply topical steroids and continue the drug
  • Perform patch testing before stopping drugs

Correct Answer: Immediately discontinue the suspected offending drug(s)

Q11. Which is the most appropriate initial inpatient management strategy for a patient with extensive epidermal detachment from TEN?

  • Immediate transfer to a burn or specialized intensive care unit for supportive care (fluid, electrolytes, wound management)
  • Routine dermatology outpatient follow‑up
  • High‑dose oral antibiotics only
  • Topical antiseptics at home

Correct Answer: Immediate transfer to a burn or specialized intensive care unit for supportive care (fluid, electrolytes, wound management)

Q12. Which drug is classically implicated as a common trigger of DRESS syndrome?

  • Allopurinol
  • Paracetamol (acetaminophen)
  • Topical corticosteroids
  • Oral probiotics

Correct Answer: Allopurinol

Q13. Which laboratory finding is most characteristic of DRESS syndrome?

  • Eosinophilia with evidence of systemic organ involvement (e.g., elevated liver enzymes)
  • Neutropenia without other abnormalities
  • Isolated thrombocytopenia only
  • Normal blood counts and chemistry always

Correct Answer: Eosinophilia with evidence of systemic organ involvement (e.g., elevated liver enzymes)

Q14. What is the mainstay of pharmacologic therapy for severe DRESS with organ involvement?

  • Systemic corticosteroids (e.g., oral prednisone or IV methylprednisolone)
  • Topical emollients only
  • Long‑term oral antibiotics
  • Oral antihistamines alone

Correct Answer: Systemic corticosteroids (e.g., oral prednisone or IV methylprednisolone)

Q15. Which statement about systemic corticosteroid use in SJS/TEN is most accurate?

  • Systemic corticosteroids are universally recommended and clearly reduce mortality in all cases
  • Their use is controversial; they may help if given very early but can increase infection risk and are not uniformly recommended
  • They are contraindicated in all cases of SJS/TEN
  • They should always be given topically instead of systemically

Correct Answer: Their use is controversial; they may help if given very early but can increase infection risk and are not uniformly recommended

Q16. Intravenous immunoglobulin (IVIG) is proposed to benefit SJS/TEN by which primary mechanism?

  • Neutralization of Fas‑mediated keratinocyte apoptosis
  • Direct antibacterial activity against skin flora
  • Stimulation of epidermal proliferation
  • Blockade of histamine H1 receptors

Correct Answer: Neutralization of Fas‑mediated keratinocyte apoptosis

Q17. Cyclosporine has been used in severe SJS/TEN. What is its main therapeutic action relevant to these reactions?

  • Inhibition of T‑cell activation via calcineurin blockade
  • Direct keratinocyte antibacterial effect
  • Activation of eosinophils
  • Enhancement of complement activation

Correct Answer: Inhibition of T‑cell activation via calcineurin blockade

Q18. Which class of drugs is most commonly associated with acute generalized exanthematous pustulosis (AGEP)?

  • Beta‑lactam antibiotics (e.g., aminopenicillins)
  • Topical retinoids
  • Proton pump inhibitors
  • Statins

Correct Answer: Beta‑lactam antibiotics (e.g., aminopenicillins)

Q19. Which diagnostic test can be useful in identifying the culprit drug in certain delayed T‑cell mediated cutaneous drug reactions?

  • Patch testing (useful for some delayed drug eruptions)
  • Skin prick testing (best for delayed reactions)
  • Serum IgE specific testing for all delayed reactions
  • Urine drug levels

Correct Answer: Patch testing (useful for some delayed drug eruptions)

Q20. For recurrent household impetigo with S. aureus carriage, which decolonization strategy is recommended to reduce transmission?

  • Intranasal mupirocin plus chlorhexidine body washes for household contacts
  • Year‑long oral antibiotics for all family members
  • Daily topical steroids to carriers
  • Immediate vaccination against S. aureus

Correct Answer: Intranasal mupirocin plus chlorhexidine body washes for household contacts

Author

  • G S Sachin Author Pharmacy Freak
    : Author

    G S Sachin is a Registered Pharmacist under the Pharmacy Act, 1948, and the founder of PharmacyFreak.com. He holds a Bachelor of Pharmacy degree from Rungta College of Pharmaceutical Science and Research and creates clear, accurate educational content on pharmacology, drug mechanisms of action, pharmacist learning, and GPAT exam preparation.

    Mail- Sachin@pharmacyfreak.com

Leave a Comment

PRO
Ad-Free Access
$3.99 / month
  • No Interruptions
  • Faster Page Loads
  • Support Content Creators